A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma
Titel:
A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma
Auteur:
Morschhauser, F. Seymour, J.F. Kluin-Nelemans, H.C. Grigg, A. Wolf, M. Pfreundschuh, M. Tilly, H. Raemaekers, J. van ’t Veer, M.B. Milpied, N. Cartron, G. Pezzutto, A. Spencer, A. Reyes, F. Dreyling, M.